{"id":358323,"date":"2025-08-29T12:14:01","date_gmt":"2025-08-29T12:14:01","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-silence-therapeutics\/"},"modified":"2025-08-29T12:14:01","modified_gmt":"2025-08-29T12:14:01","slug":"how-to-buy-silence-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/","title":{"rendered":"Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Silence Therapeutics plc (SLN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-358323","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Silence Therapeutics plc (SLN) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Silence Therapeutics plc (SLN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Silence Therapeutics plc (SLN) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu yenilik\u00e7i biyotek hisse senedine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel fiyat, trendler ve 2025 yat\u0131r\u0131m f\u0131rsatlar\u0131n\u0131 ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Silence Therapeutics plc (SLN) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu yenilik\u00e7i biyotek hisse senedine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel fiyat, trendler ve 2025 yat\u0131r\u0131m f\u0131rsatlar\u0131n\u0131 ke\u015ffedin."},"intro":"Genetik t\u0131ptaki bir sonraki at\u0131l\u0131m\u0131n bir par\u00e7as\u0131na sahip oldu\u011funuzu hayal edin. Silence Therapeutics (SLN) sadece ba\u015fka bir biyotek hisse senedi de\u011fil\u2014nadir hastal\u0131klar\u0131n tedavisinde devrim yaratabilecek RNA interferans teknolojisinde \u00f6nc\u00fc bir \u015firkettir. Polistemiya vera ve kardiyovask\u00fcler durumlar\u0131 hedefleyen ileri siRNA platformlar\u0131yla bu \u015firket, hassas t\u0131bb\u0131n gelece\u011fini temsil ediyor. SLN'nin biyotek devriminin kap\u0131s\u0131 olmas\u0131n\u0131n nedenlerini ve bunu yat\u0131r\u0131m yolculu\u011funuzun bir par\u00e7as\u0131 haline nas\u0131l getirebilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Genetik t\u0131ptaki bir sonraki at\u0131l\u0131m\u0131n bir par\u00e7as\u0131na sahip oldu\u011funuzu hayal edin. Silence Therapeutics (SLN) sadece ba\u015fka bir biyotek hisse senedi de\u011fil\u2014nadir hastal\u0131klar\u0131n tedavisinde devrim yaratabilecek RNA interferans teknolojisinde \u00f6nc\u00fc bir \u015firkettir. Polistemiya vera ve kardiyovask\u00fcler durumlar\u0131 hedefleyen ileri siRNA platformlar\u0131yla bu \u015firket, hassas t\u0131bb\u0131n gelece\u011fini temsil ediyor. SLN'nin biyotek devriminin kap\u0131s\u0131 olmas\u0131n\u0131n nedenlerini ve bunu yat\u0131r\u0131m yolculu\u011funuzun bir par\u00e7as\u0131 haline nas\u0131l getirebilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>G\u00fcncel Hisse Fiyat\u0131 ve \u00d6nemli Tarihler<\/h2> <p>29 A\u011fustos 2025 itibar\u0131yla Silence Therapeutics plc (SLN) hisseleri <strong>5,10 $<\/strong> fiyatla i\u015flem g\u00f6rmektedir. Takviminize <strong>13 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin\u2014\u015firketin 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih ve tarihsel olarak bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden olmaktad\u0131r.<\/p> <p>7 A\u011fustos 2025'teki en son kazan\u00e7 raporu, \u015firketin -0,54 $ EPS ve 0,22 milyon $ gelir bildirdi\u011fini g\u00f6sterdi (<a href=\"https:\/\/www.marketbeat.com\/earnings\/reports\/2025-8-7-silence-therapeutics-plc-stock\/\">MarketBeat Kazan\u00e7 Raporu<\/a>). \u00d6nceki \u00e7eyrekler, klinik deneme g\u00fcncellemelerinin SLN'nin de\u011ferlemesini nas\u0131l dramatik \u015fekilde etkileyebilece\u011fini g\u00f6stermi\u015ftir.<\/p> <h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3> <p>Son performans desenlerine bak\u0131ld\u0131\u011f\u0131nda:<\/p> <ul> <li><strong>7 A\u011fustos 2025<\/strong>: 2. \u00c7eyrek Kazan\u00e7lar\u0131 - Hisse, klinik deneme g\u00fcncellemeleri etraf\u0131nda artan volatilite ile tepki verdi<\/li> <li><strong>May\u0131s 2025<\/strong>: 1. \u00c7eyrek Kazan\u00e7lar\u0131 - 142.000 $ gelir ve 2028'e kadar nakit pozisyonunun uzat\u0131lmas\u0131na odaklanma<\/li> <li><strong>Ocak 2025<\/strong>: Klinik deneme gerilemesi - %21,81 tek g\u00fcnl\u00fck d\u00fc\u015f\u00fc\u015f (<a href=\"https:\/\/tickeron.com\/trading-investing-101\/slxn-stock-surges-2414-in-2025-what-drove-the-rally-and-can-it-continue\/\">Tickeron Analizi<\/a>)<\/li> <\/ul> <p>Desen a\u00e7\u0131k: pozitif klinik veriler rallileri tetiklerken, gerilemeler keskin d\u00fc\u015f\u00fc\u015flere neden oluyor. Bu Kas\u0131m ay\u0131ndaki kazan\u00e7lar \u00f6zellikle kritik olacak \u00e7\u00fcnk\u00fc SANRECO Faz 2 \u00e7al\u0131\u015fmas\u0131n\u0131n kay\u0131t ilerlemesi hakk\u0131nda g\u00fcncellemeler i\u00e7erebilir.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>Alt\u0131 Ayl\u0131k Fiyat Yolculu\u011fu: S\u00f6z Verilen Bir Rollercoaster<\/h2> <p>Silence Therapeutics, son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 \u00e7alkant\u0131l\u0131 bir yolculu\u011fa \u00e7\u0131kard\u0131; genel olarak <strong>%74,91<\/strong> d\u00fc\u015f\u00fc\u015f ya\u015farken son \u00fc\u00e7 ayda <strong>%96,5 kazan\u00e7<\/strong> g\u00f6sterdi (<a href=\"https:\/\/stockanalysis.com\/stocks\/sln\/forecast\/\">Hisse Analizi<\/a>).<\/p> <p><strong>Ocak-Mart 2025<\/strong>: D\u00f6nem, klinik deneme hayal k\u0131r\u0131kl\u0131\u011f\u0131 ile ba\u015flad\u0131 ve hisseler 52 haftal\u0131k dip seviyelere yakla\u015ft\u0131. Hisse en d\u00fc\u015f\u00fck noktada 1,97 $'a geriledi ve bir\u00e7ok analistin \u015fimdi potansiyel bir dip olarak g\u00f6rd\u00fc\u011f\u00fc bir durum yaratt\u0131.<\/p> <p><strong>Nisan-Haziran 2025<\/strong>: \u015eirket, t\u0131bbi konferanslarda divesiran i\u00e7in umut verici Faz 1 verileri sunduk\u00e7a kademeli bir toparlanma ba\u015flad\u0131. Hisse 2-3 $ aral\u0131\u011f\u0131ndan 4-5 $ seviyelerine do\u011fru y\u00fckseldi.<\/p> <p><strong>Temmuz-A\u011fustos 2025<\/strong>: Ger\u00e7ek ivme, SANRECO Faz 2 \u00e7al\u0131\u015fmas\u0131n\u0131n %50'nin \u00fczerinde kay\u0131t yapmas\u0131 ve zerlasiran i\u00e7in olumlu d\u00fczenleyici geri bildirimlerle olu\u015ftu. Hisseler Temmuz sonlar\u0131nda 6,20 $'a kadar \u00e7\u0131kt\u0131 ve ard\u0131ndan mevcut seviyelere yerle\u015fti.<\/p> <p>Bu volatilite cesaret isteyen bir durumdur ancak biyotek d\u00f6ng\u00fclerini anlayan stratejik yat\u0131r\u0131mc\u0131lar i\u00e7in f\u0131rsatlar yarat\u0131r.<\/p> <h2>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist konsens\u00fcs\u00fc ve klinik d\u00f6n\u00fcm noktalar\u0131na dayanarak, gelecekte \u015funlar olabilir:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: Ortalama hedef <strong>33,83 $<\/strong> (%563 y\u00fckseli\u015f) ve y\u00fcksek tahminler <strong>75,00 $<\/strong> seviyesine ula\u015fabilir (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/SLN\/forecast\/\">MarketBeat Tahmini<\/a>). Ana itici g\u00fc\u00e7 SANRECO Faz 2 tam kay\u0131t tamamlanmas\u0131 olacak.<\/li> <li><strong>2026 Projeksiyonu<\/strong>: Pozitif Faz 2 verileri ve zerlasiran Faz 3 geli\u015ftirme i\u00e7in potansiyel ortakl\u0131k duyurular\u0131 varsay\u0131larak <strong>40-60 $ aral\u0131\u011f\u0131<\/strong>.<\/li> <li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: Divesiran d\u00fczenleyici onay al\u0131r ve polistemiya vera tedavisinde ticari ba\u015far\u0131 elde ederse <strong>80-120 $ potansiyeli<\/strong>.<\/li> <li><strong>2030 Vizyonu<\/strong>: Birden fazla onayl\u0131 terapi ve mRNAi GOLD\u2122 platformunu kullanan geni\u015fletilmi\u015f \u00fcr\u00fcn hatt\u0131 ile <strong>150 $+<\/strong> ula\u015f\u0131labilir.<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: 3-5 y\u0131ll\u0131k ufku olan risk tolerans\u0131 y\u00fcksek yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM \u00f6nerisi.<\/p> <h2>Risk Analizi: Biyotek Volatilitesinde Yol Alma<\/h2> <h3>Y\u00fcksek Risk Fakt\u00f6rleri<\/h3> <ul> <li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131\u011f\u0131 Riski<\/strong>: Ocak 2025'teki %21,81 d\u00fc\u015f\u00fc\u015f, olumsuz sonu\u00e7lar\u0131n ne kadar y\u0131k\u0131c\u0131 olabilece\u011fini g\u00f6steriyor (<a href=\"https:\/\/tickeron.com\/trading-investing-101\/slxn-stock-surges-2414-in-2025-what-drove-the-rally-and-can-it-continue\/\">Tickeron<\/a>)<\/li> <li><strong>Mali S\u00fcrd\u00fcr\u00fclebilirlik<\/strong>: Negatif k\u00e2rl\u0131l\u0131k marjlar\u0131 ve y\u00fcksek nakit t\u00fcketim oran\u0131 dikkatli izleme gerektirir<\/li> <li><strong>D\u00fczenleyici Engeller<\/strong>: FDA onaylar\u0131 \u00f6zellikle s\u0131n\u0131f\u0131nda ilk tedaviler i\u00e7in asla garanti de\u011fildir<\/li> <li><strong>Rekabet<\/strong>: Benzer KRAS hedefli tedaviler geli\u015ftiren b\u00fcy\u00fck ila\u00e7 \u015firketleri<\/li> <\/ul> <h3>2025 \u0130\u00e7in Pozitif Kataliz\u00f6rler<\/h3> <ul> <li><strong>SANRECO Faz 2 Tamamlanmas\u0131<\/strong>: 2025 sonuna kadar tam kay\u0131t bekleniyor<\/li> <li><strong>Ortakl\u0131k F\u0131rsatlar\u0131<\/strong>: Zerlasiran Faz 3 geli\u015ftirme i\u00e7in aktif g\u00f6r\u00fc\u015fmeler<\/li> <li><strong>Divesiran Verileri<\/strong>: Polistemiya vera tedavisi i\u00e7in umut vadeden ek Faz 1 sonu\u00e7lar\u0131<\/li> <li><strong>Mali Ko\u015fullar<\/strong>: 2028'e kadar uzanan 136+ milyon $ nakit pozisyonu<\/li> <\/ul> <h2>Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5'inden fazlas\u0131n\u0131 SLN gibi y\u00fcksek riskli biyotek hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Ortalama Maliyetle Al\u0131m<\/strong>: Tek seferlik b\u00fcy\u00fck al\u0131m yerine, zamanlama riskini azaltmak i\u00e7in d\u00fczenli k\u00fc\u00e7\u00fck yat\u0131r\u0131mlar yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Uyar\u0131 Seviyeleri Belirleyin<\/strong>: F\u0131rsatlar\u0131 yakalamak i\u00e7in 4,50 $ (destek) ve 6,50 $ (diren\u00e7) fiyat uyar\u0131lar\u0131 koyun<\/li> <li><strong>Klinik D\u00f6n\u00fcm Noktalar\u0131n\u0131 Takip Edin<\/strong>: 13 Kas\u0131m kazan\u00e7lar\u0131n\u0131 i\u015faretleyin ve SANRECO kay\u0131t g\u00fcncellemelerini izleyin<\/li> <\/ol> <p>Mizahi deneyimli tavsiye: \"SLN ticareti, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014deneyler i\u015fe yarad\u0131\u011f\u0131nda inan\u0131lmaz heyecan verici, ama yol boyunca baz\u0131 patlay\u0131c\u0131 ba\u015far\u0131s\u0131zl\u0131klara haz\u0131rl\u0131kl\u0131 olun!\"<\/p> <h2>Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NASDAQ listeleri ve kesirli hisse sunan bir platform oldu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>\u00c7o\u011fu platform kimlik ve adres kan\u0131t\u0131 ister<\/td><\/tr> <tr><td>3<\/td><td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"SLN\" Aramas\u0131 Yap\u0131n<\/td><td>\u015eirketin tam ad\u0131 yerine borsa sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>Emir Detaylar\u0131n\u0131 G\u00f6zden Ge\u00e7irin<\/td><td>Komisyon \u00fccretleri ve takas tarihlerini kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Al\u0131m\u0131 Ger\u00e7ekle\u015ftirin<\/td><td>\u0130\u015fleminizi onaylay\u0131n ve portf\u00f6y takibini kurun<\/td><\/tr> <\/tbody> <\/table> <h2>Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option'\u0131n Cazibesi<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, piyasaya giri\u015fin daha az korkutucu olmas\u0131n\u0131 sa\u011flayan birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum Yat\u0131r\u0131m Sadece 5 $<\/strong> - Neredeyse herhangi bir miktarla ba\u015flayabilirsiniz, bu da stratejileri b\u00fcy\u00fck finansal taahh\u00fct olmadan test etmek i\u00e7in m\u00fckemmeldir.<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama S\u00fcreci<\/strong> - Tek bir belge y\u00fcklemesiyle KYC tamamlan\u0131r ve dakikalar i\u00e7inde ticarete ba\u015flanabilir, g\u00fcnler de\u011fil.<\/li> <li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong> - Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil y\u00fczlerce y\u00f6ntemle karlar\u0131n\u0131za eri\u015fim sa\u011flar.<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve d\u00fc\u015f\u00fck giri\u015f engelleri, Silence Therapeutics gibi umut vadeden \u015firketlerde pozisyon olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in ideal bir ortam sunar.<\/p> <h2>\u015eirket Genel Bak\u0131\u015f\u0131: Silence Therapeutics 2025'te<\/h2> <p>Silence Therapeutics, genetik t\u0131p inovasyonunun \u00f6n saflar\u0131nda yer almaktad\u0131r. \u015eirket, hastal\u0131\u011fa neden olan genleri hassas \u015fekilde hedeflemek i\u00e7in kendi mRNAi GOLD\u2122 platformunu kullanan siRNA (k\u00fc\u00e7\u00fck giri\u015fimci RNA) terapilerine odaklanmaktad\u0131r.<\/p> <p><strong>Mevcut Odak<\/strong>: ABD'de yakla\u015f\u0131k 100.000 hastay\u0131 etkileyen nadir bir kan hastal\u0131\u011f\u0131 olan polistemiya vera i\u00e7in divesiran'\u0131 Faz 2 denemeleriyle ilerletmek. Tedavi, d\u00fczenli flebotomilere olan ihtiyac\u0131 ortadan kald\u0131rma potansiyeli ta\u015f\u0131yor\u2014bu da ya\u015fam kalitesinde \u00f6nemli bir iyile\u015fme demek.<\/p> <p><strong>Pazar Konumu<\/strong>: 291 milyon $ piyasa de\u011feri ile k\u00fc\u00e7\u00fck \u00f6l\u00e7ekli bir biyotek \u015firketi olarak SLN, teknolojik inovasyonda a\u011f\u0131rl\u0131\u011f\u0131n\u0131n \u00fczerinde bir etki yarat\u0131rken klinik sonu\u00e7lara ba\u011fl\u0131 olarak h\u0131zl\u0131ca y\u00f6n de\u011fi\u015ftirebilme \u00e7evikli\u011fini koruyor.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Silence Therapeutics'in ara\u015ft\u0131rma tesisi, RNA katlanma desenlerini %94 do\u011frulukla tahmin edebilen bir yapay zeka sistemi geli\u015ftirdi\u2014bu, ila\u00e7 geli\u015ftirme s\u00fcresini aylarca k\u0131salt\u0131yor ve Ar-Ge maliyetlerinde milyonlarca dolar tasarruf potansiyeli sunuyor. Bu teknolojik avantaj, yeni tedavileri pazara getirme h\u0131zlar\u0131n\u0131 devrim niteli\u011finde art\u0131rabilir.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>G\u00fcncel Hisse Fiyat\u0131 ve \u00d6nemli Tarihler<\/h2>\n<p>29 A\u011fustos 2025 itibar\u0131yla Silence Therapeutics plc (SLN) hisseleri <strong>5,10 $<\/strong> fiyatla i\u015flem g\u00f6rmektedir. Takviminize <strong>13 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin\u2014\u015firketin 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih ve tarihsel olarak bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden olmaktad\u0131r.<\/p>\n<p>7 A\u011fustos 2025&#8217;teki en son kazan\u00e7 raporu, \u015firketin -0,54 $ EPS ve 0,22 milyon $ gelir bildirdi\u011fini g\u00f6sterdi (<a href=\"https:\/\/www.marketbeat.com\/earnings\/reports\/2025-8-7-silence-therapeutics-plc-stock\/\">MarketBeat Kazan\u00e7 Raporu<\/a>). \u00d6nceki \u00e7eyrekler, klinik deneme g\u00fcncellemelerinin SLN&#8217;nin de\u011ferlemesini nas\u0131l dramatik \u015fekilde etkileyebilece\u011fini g\u00f6stermi\u015ftir.<\/p>\n<h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3>\n<p>Son performans desenlerine bak\u0131ld\u0131\u011f\u0131nda:<\/p>\n<ul>\n<li><strong>7 A\u011fustos 2025<\/strong>: 2. \u00c7eyrek Kazan\u00e7lar\u0131 &#8211; Hisse, klinik deneme g\u00fcncellemeleri etraf\u0131nda artan volatilite ile tepki verdi<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 1. \u00c7eyrek Kazan\u00e7lar\u0131 &#8211; 142.000 $ gelir ve 2028&#8217;e kadar nakit pozisyonunun uzat\u0131lmas\u0131na odaklanma<\/li>\n<li><strong>Ocak 2025<\/strong>: Klinik deneme gerilemesi &#8211; %21,81 tek g\u00fcnl\u00fck d\u00fc\u015f\u00fc\u015f (<a href=\"https:\/\/tickeron.com\/trading-investing-101\/slxn-stock-surges-2414-in-2025-what-drove-the-rally-and-can-it-continue\/\">Tickeron Analizi<\/a>)<\/li>\n<\/ul>\n<p>Desen a\u00e7\u0131k: pozitif klinik veriler rallileri tetiklerken, gerilemeler keskin d\u00fc\u015f\u00fc\u015flere neden oluyor. Bu Kas\u0131m ay\u0131ndaki kazan\u00e7lar \u00f6zellikle kritik olacak \u00e7\u00fcnk\u00fc SANRECO Faz 2 \u00e7al\u0131\u015fmas\u0131n\u0131n kay\u0131t ilerlemesi hakk\u0131nda g\u00fcncellemeler i\u00e7erebilir.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>Alt\u0131 Ayl\u0131k Fiyat Yolculu\u011fu: S\u00f6z Verilen Bir Rollercoaster<\/h2>\n<p>Silence Therapeutics, son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 \u00e7alkant\u0131l\u0131 bir yolculu\u011fa \u00e7\u0131kard\u0131; genel olarak <strong>%74,91<\/strong> d\u00fc\u015f\u00fc\u015f ya\u015farken son \u00fc\u00e7 ayda <strong>%96,5 kazan\u00e7<\/strong> g\u00f6sterdi (<a href=\"https:\/\/stockanalysis.com\/stocks\/sln\/forecast\/\">Hisse Analizi<\/a>).<\/p>\n<p><strong>Ocak-Mart 2025<\/strong>: D\u00f6nem, klinik deneme hayal k\u0131r\u0131kl\u0131\u011f\u0131 ile ba\u015flad\u0131 ve hisseler 52 haftal\u0131k dip seviyelere yakla\u015ft\u0131. Hisse en d\u00fc\u015f\u00fck noktada 1,97 $&#8217;a geriledi ve bir\u00e7ok analistin \u015fimdi potansiyel bir dip olarak g\u00f6rd\u00fc\u011f\u00fc bir durum yaratt\u0131.<\/p>\n<p><strong>Nisan-Haziran 2025<\/strong>: \u015eirket, t\u0131bbi konferanslarda divesiran i\u00e7in umut verici Faz 1 verileri sunduk\u00e7a kademeli bir toparlanma ba\u015flad\u0131. Hisse 2-3 $ aral\u0131\u011f\u0131ndan 4-5 $ seviyelerine do\u011fru y\u00fckseldi.<\/p>\n<p><strong>Temmuz-A\u011fustos 2025<\/strong>: Ger\u00e7ek ivme, SANRECO Faz 2 \u00e7al\u0131\u015fmas\u0131n\u0131n %50&#8217;nin \u00fczerinde kay\u0131t yapmas\u0131 ve zerlasiran i\u00e7in olumlu d\u00fczenleyici geri bildirimlerle olu\u015ftu. Hisseler Temmuz sonlar\u0131nda 6,20 $&#8217;a kadar \u00e7\u0131kt\u0131 ve ard\u0131ndan mevcut seviyelere yerle\u015fti.<\/p>\n<p>Bu volatilite cesaret isteyen bir durumdur ancak biyotek d\u00f6ng\u00fclerini anlayan stratejik yat\u0131r\u0131mc\u0131lar i\u00e7in f\u0131rsatlar yarat\u0131r.<\/p>\n<h2>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist konsens\u00fcs\u00fc ve klinik d\u00f6n\u00fcm noktalar\u0131na dayanarak, gelecekte \u015funlar olabilir:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: Ortalama hedef <strong>33,83 $<\/strong> (%563 y\u00fckseli\u015f) ve y\u00fcksek tahminler <strong>75,00 $<\/strong> seviyesine ula\u015fabilir (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/SLN\/forecast\/\">MarketBeat Tahmini<\/a>). Ana itici g\u00fc\u00e7 SANRECO Faz 2 tam kay\u0131t tamamlanmas\u0131 olacak.<\/li>\n<li><strong>2026 Projeksiyonu<\/strong>: Pozitif Faz 2 verileri ve zerlasiran Faz 3 geli\u015ftirme i\u00e7in potansiyel ortakl\u0131k duyurular\u0131 varsay\u0131larak <strong>40-60 $ aral\u0131\u011f\u0131<\/strong>.<\/li>\n<li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: Divesiran d\u00fczenleyici onay al\u0131r ve polistemiya vera tedavisinde ticari ba\u015far\u0131 elde ederse <strong>80-120 $ potansiyeli<\/strong>.<\/li>\n<li><strong>2030 Vizyonu<\/strong>: Birden fazla onayl\u0131 terapi ve mRNAi GOLD\u2122 platformunu kullanan geni\u015fletilmi\u015f \u00fcr\u00fcn hatt\u0131 ile <strong>150 $+<\/strong> ula\u015f\u0131labilir.<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: 3-5 y\u0131ll\u0131k ufku olan risk tolerans\u0131 y\u00fcksek yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM \u00f6nerisi.<\/p>\n<h2>Risk Analizi: Biyotek Volatilitesinde Yol Alma<\/h2>\n<h3>Y\u00fcksek Risk Fakt\u00f6rleri<\/h3>\n<ul>\n<li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131\u011f\u0131 Riski<\/strong>: Ocak 2025&#8217;teki %21,81 d\u00fc\u015f\u00fc\u015f, olumsuz sonu\u00e7lar\u0131n ne kadar y\u0131k\u0131c\u0131 olabilece\u011fini g\u00f6steriyor (<a href=\"https:\/\/tickeron.com\/trading-investing-101\/slxn-stock-surges-2414-in-2025-what-drove-the-rally-and-can-it-continue\/\">Tickeron<\/a>)<\/li>\n<li><strong>Mali S\u00fcrd\u00fcr\u00fclebilirlik<\/strong>: Negatif k\u00e2rl\u0131l\u0131k marjlar\u0131 ve y\u00fcksek nakit t\u00fcketim oran\u0131 dikkatli izleme gerektirir<\/li>\n<li><strong>D\u00fczenleyici Engeller<\/strong>: FDA onaylar\u0131 \u00f6zellikle s\u0131n\u0131f\u0131nda ilk tedaviler i\u00e7in asla garanti de\u011fildir<\/li>\n<li><strong>Rekabet<\/strong>: Benzer KRAS hedefli tedaviler geli\u015ftiren b\u00fcy\u00fck ila\u00e7 \u015firketleri<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Pozitif Kataliz\u00f6rler<\/h3>\n<ul>\n<li><strong>SANRECO Faz 2 Tamamlanmas\u0131<\/strong>: 2025 sonuna kadar tam kay\u0131t bekleniyor<\/li>\n<li><strong>Ortakl\u0131k F\u0131rsatlar\u0131<\/strong>: Zerlasiran Faz 3 geli\u015ftirme i\u00e7in aktif g\u00f6r\u00fc\u015fmeler<\/li>\n<li><strong>Divesiran Verileri<\/strong>: Polistemiya vera tedavisi i\u00e7in umut vadeden ek Faz 1 sonu\u00e7lar\u0131<\/li>\n<li><strong>Mali Ko\u015fullar<\/strong>: 2028&#8217;e kadar uzanan 136+ milyon $ nakit pozisyonu<\/li>\n<\/ul>\n<h2>Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5&#8217;inden fazlas\u0131n\u0131 SLN gibi y\u00fcksek riskli biyotek hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Ortalama Maliyetle Al\u0131m<\/strong>: Tek seferlik b\u00fcy\u00fck al\u0131m yerine, zamanlama riskini azaltmak i\u00e7in d\u00fczenli k\u00fc\u00e7\u00fck yat\u0131r\u0131mlar yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Uyar\u0131 Seviyeleri Belirleyin<\/strong>: F\u0131rsatlar\u0131 yakalamak i\u00e7in 4,50 $ (destek) ve 6,50 $ (diren\u00e7) fiyat uyar\u0131lar\u0131 koyun<\/li>\n<li><strong>Klinik D\u00f6n\u00fcm Noktalar\u0131n\u0131 Takip Edin<\/strong>: 13 Kas\u0131m kazan\u00e7lar\u0131n\u0131 i\u015faretleyin ve SANRECO kay\u0131t g\u00fcncellemelerini izleyin<\/li>\n<\/ol>\n<p>Mizahi deneyimli tavsiye: &#8220;SLN ticareti, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014deneyler i\u015fe yarad\u0131\u011f\u0131nda inan\u0131lmaz heyecan verici, ama yol boyunca baz\u0131 patlay\u0131c\u0131 ba\u015far\u0131s\u0131zl\u0131klara haz\u0131rl\u0131kl\u0131 olun!&#8221;<\/p>\n<h2>Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ listeleri ve kesirli hisse sunan bir platform oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>\u00c7o\u011fu platform kimlik ve adres kan\u0131t\u0131 ister<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;SLN&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>\u015eirketin tam ad\u0131 yerine borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Emir Detaylar\u0131n\u0131 G\u00f6zden Ge\u00e7irin<\/td>\n<td>Komisyon \u00fccretleri ve takas tarihlerini kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Al\u0131m\u0131 Ger\u00e7ekle\u015ftirin<\/td>\n<td>\u0130\u015fleminizi onaylay\u0131n ve portf\u00f6y takibini kurun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option&#8217;\u0131n Cazibesi<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, piyasaya giri\u015fin daha az korkutucu olmas\u0131n\u0131 sa\u011flayan birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum Yat\u0131r\u0131m Sadece 5 $<\/strong> &#8211; Neredeyse herhangi bir miktarla ba\u015flayabilirsiniz, bu da stratejileri b\u00fcy\u00fck finansal taahh\u00fct olmadan test etmek i\u00e7in m\u00fckemmeldir.<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama S\u00fcreci<\/strong> &#8211; Tek bir belge y\u00fcklemesiyle KYC tamamlan\u0131r ve dakikalar i\u00e7inde ticarete ba\u015flanabilir, g\u00fcnler de\u011fil.<\/li>\n<li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong> &#8211; Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil y\u00fczlerce y\u00f6ntemle karlar\u0131n\u0131za eri\u015fim sa\u011flar.<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ve d\u00fc\u015f\u00fck giri\u015f engelleri, Silence Therapeutics gibi umut vadeden \u015firketlerde pozisyon olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in ideal bir ortam sunar.<\/p>\n<h2>\u015eirket Genel Bak\u0131\u015f\u0131: Silence Therapeutics 2025&#8217;te<\/h2>\n<p>Silence Therapeutics, genetik t\u0131p inovasyonunun \u00f6n saflar\u0131nda yer almaktad\u0131r. \u015eirket, hastal\u0131\u011fa neden olan genleri hassas \u015fekilde hedeflemek i\u00e7in kendi mRNAi GOLD\u2122 platformunu kullanan siRNA (k\u00fc\u00e7\u00fck giri\u015fimci RNA) terapilerine odaklanmaktad\u0131r.<\/p>\n<p><strong>Mevcut Odak<\/strong>: ABD&#8217;de yakla\u015f\u0131k 100.000 hastay\u0131 etkileyen nadir bir kan hastal\u0131\u011f\u0131 olan polistemiya vera i\u00e7in divesiran&#8217;\u0131 Faz 2 denemeleriyle ilerletmek. Tedavi, d\u00fczenli flebotomilere olan ihtiyac\u0131 ortadan kald\u0131rma potansiyeli ta\u015f\u0131yor\u2014bu da ya\u015fam kalitesinde \u00f6nemli bir iyile\u015fme demek.<\/p>\n<p><strong>Pazar Konumu<\/strong>: 291 milyon $ piyasa de\u011feri ile k\u00fc\u00e7\u00fck \u00f6l\u00e7ekli bir biyotek \u015firketi olarak SLN, teknolojik inovasyonda a\u011f\u0131rl\u0131\u011f\u0131n\u0131n \u00fczerinde bir etki yarat\u0131rken klinik sonu\u00e7lara ba\u011fl\u0131 olarak h\u0131zl\u0131ca y\u00f6n de\u011fi\u015ftirebilme \u00e7evikli\u011fini koruyor.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Silence Therapeutics&#8217;in ara\u015ft\u0131rma tesisi, RNA katlanma desenlerini %94 do\u011frulukla tahmin edebilen bir yapay zeka sistemi geli\u015ftirdi\u2014bu, ila\u00e7 geli\u015ftirme s\u00fcresini aylarca k\u0131salt\u0131yor ve Ar-Ge maliyetlerinde milyonlarca dolar tasarruf potansiyeli sunuyor. Bu teknolojik avantaj, yeni tedavileri pazara getirme h\u0131zlar\u0131n\u0131 devrim niteli\u011finde art\u0131rabilir.<\/p>\n"},"faq":[{"question":"Silence Therapeutics (SLN) hisseleri nereden al\u0131nabilir?","answer":"SLN hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"SLN hisseleri almak i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 platforma g\u00f6re de\u011fi\u015fir ancak Pocket Option gibi platformlarda 5 $ gibi d\u00fc\u015f\u00fck bir miktarla ba\u015flayabilirsiniz."},{"question":"Silence Therapeutics'in ana tedavi alanlar\u0131 nelerdir?","answer":"\u015eirket, polistemiya vera ve kardiyovask\u00fcler hastal\u0131klar gibi nadir hastal\u0131klar\u0131 hedefleyen siRNA terapileri geli\u015ftirmektedir."},{"question":"SLN hisselerinin fiyat tahmini nedir?","answer":"Analistlerin 2025 sonu i\u00e7in ortalama hedef fiyat\u0131 33,83 $ olup, uzun vadede 150 $ ve \u00fczeri fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yat\u0131r\u0131m yaparken nelere dikkat etmeliyim?","answer":"Klinik deneme sonu\u00e7lar\u0131, finansal s\u00fcrd\u00fcr\u00fclebilirlik, d\u00fczenleyici onaylar ve piyasa rekabeti gibi risk fakt\u00f6rlerini g\u00f6z \u00f6n\u00fcnde bulundurmal\u0131s\u0131n\u0131z."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Silence Therapeutics (SLN) hisseleri nereden al\u0131nabilir?","answer":"SLN hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"SLN hisseleri almak i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 platforma g\u00f6re de\u011fi\u015fir ancak Pocket Option gibi platformlarda 5 $ gibi d\u00fc\u015f\u00fck bir miktarla ba\u015flayabilirsiniz."},{"question":"Silence Therapeutics'in ana tedavi alanlar\u0131 nelerdir?","answer":"\u015eirket, polistemiya vera ve kardiyovask\u00fcler hastal\u0131klar gibi nadir hastal\u0131klar\u0131 hedefleyen siRNA terapileri geli\u015ftirmektedir."},{"question":"SLN hisselerinin fiyat tahmini nedir?","answer":"Analistlerin 2025 sonu i\u00e7in ortalama hedef fiyat\u0131 33,83 $ olup, uzun vadede 150 $ ve \u00fczeri fiyatlar \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yat\u0131r\u0131m yaparken nelere dikkat etmeliyim?","answer":"Klinik deneme sonu\u00e7lar\u0131, finansal s\u00fcrd\u00fcr\u00fclebilirlik, d\u00fczenleyici onaylar ve piyasa rekabeti gibi risk fakt\u00f6rlerini g\u00f6z \u00f6n\u00fcnde bulundurmal\u0131s\u0131n\u0131z."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Silence Therapeutics plc (SLN) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Silence Therapeutics plc (SLN) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T12:14:01+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Silence Therapeutics plc (SLN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-29T12:14:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/\",\"name\":\"Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Silence Therapeutics plc (SLN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-29T12:14:01+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Silence Therapeutics plc (SLN) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Silence Therapeutics plc (SLN) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/","og_locale":"tr_TR","og_type":"article","og_title":"Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Silence Therapeutics plc (SLN) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T12:14:01+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Silence Therapeutics plc (SLN) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-29T12:14:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/","name":"Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Silence Therapeutics plc (SLN) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-29T12:14:01+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-silence-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Silence Therapeutics plc (SLN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Silence Therapeutics plc (SLN) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":358325,"slug":"how-to-buy-silence-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Silence Therapeutics plc (SLN)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-silence-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":358319,"slug":"how-to-buy-silence-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Silence Therapeutics plc (SLN) - Investimento em a\u00e7\u00f5es da Silence Therapeutics plc (SLN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-silence-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/358323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=358323"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/358323\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=358323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=358323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=358323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}